A detailed history of Price T Rowe Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 22,472,076 shares of MRK stock, worth $2.19 Billion. This represents 0.29% of its overall portfolio holdings.

Number of Shares
22,472,076
Previous 24,725,061 9.11%
Holding current value
$2.19 Billion
Previous $3.06 Billion 16.63%
% of portfolio
0.29%
Previous 0.37%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $250 Million - $291 Million
-2,252,985 Reduced 9.11%
22,472,076 $2.55 Billion
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $608 Million - $653 Million
-4,914,456 Reduced 16.58%
24,725,061 $3.06 Billion
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $50.7 Million - $59.1 Million
-447,700 Reduced 1.49%
29,639,517 $3.91 Billion
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $81.1 Million - $88.2 Million
809,052 Added 2.76%
30,087,217 $3.28 Billion
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $11.6 Million - $12.8 Million
-112,224 Reduced 0.38%
29,278,165 $3.01 Billion
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $48.7 Million - $53 Million
-448,026 Reduced 1.5%
29,390,389 $3.39 Billion
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $363 Million - $405 Million
3,524,385 Added 13.39%
29,838,415 $3.17 Billion
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $966 Million - $1.24 Billion
11,051,945 Added 72.41%
26,314,030 $2.92 Billion
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $149 Million - $168 Million
-1,764,865 Reduced 10.37%
15,262,085 $1.31 Billion
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $176 Million - $200 Million
2,111,477 Added 14.16%
17,026,950 $1.55 Billion
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $176 Million - $197 Million
-2,389,330 Reduced 13.81%
14,915,473 $1.22 Billion
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $86.5 Million - $108 Million
-1,197,067 Reduced 6.47%
17,304,803 $1.33 Billion
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $224 Million - $247 Million
3,128,468 Added 20.35%
18,501,870 $1.39 Billion
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $179 Million - $198 Million
-2,542,520 Reduced 14.19%
15,373,402 $1.2 Billion
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $71.6 Million - $84.4 Million
-1,040,270 Reduced 5.49%
17,915,922 $1.38 Billion
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $1.36 Billion - $1.51 Billion
18,956,192 New
18,956,192 $1.55 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.